The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
